159 related articles for article (PubMed ID: 38030890)
1. Differences in invasiveness and recurrence rate among nonfunctioning pituitary neuroendocrine tumors depending on tumor subtype.
Taguchi A; Kinoshita Y; Amatya VJ; Onishi S; Go Y; Tominaga A; Takeshima Y; Yamasaki F; Horie N
Neurosurg Rev; 2023 Nov; 46(1):317. PubMed ID: 38030890
[TBL] [Abstract][Full Text] [Related]
2. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
3. Cytodifferentiation of pituitary tumors influences pathogenesis and cavernous sinus invasion.
Asmaro K; Zhang M; Rodrigues AJ; Mohyeldin A; Vigo V; Nernekli K; Vogel H; Born DE; Katznelson L; Fernandez-Miranda JC
J Neurosurg; 2023 Nov; 139(5):1216-1224. PubMed ID: 37119095
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic Endonasal Approach to Multilobular Giant Pituitary Adenoma with Cavernous Sinus Invasion and Petroclival Extension.
Rahimli T; Hidayetov T; Rajabov T
World Neurosurg; 2021 Mar; 147():128-129. PubMed ID: 33220473
[TBL] [Abstract][Full Text] [Related]
5. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
[TBL] [Abstract][Full Text] [Related]
6. Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery.
Dickerman RD; Oldfield EH
J Neurosurg; 2002 Dec; 97(6):1343-9. PubMed ID: 12507132
[TBL] [Abstract][Full Text] [Related]
7. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.
Mete O; Gomez-Hernandez K; Kucharczyk W; Ridout R; Zadeh G; Gentili F; Ezzat S; Asa SL
Mod Pathol; 2016 Feb; 29(2):131-42. PubMed ID: 26743473
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease.
Lonser RR; Ksendzovsky A; Wind JJ; Vortmeyer AO; Oldfield EH
J Neurosurg; 2012 Feb; 116(2):272-9. PubMed ID: 21923247
[TBL] [Abstract][Full Text] [Related]
9. Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes.
Mohyeldin A; Katznelson LJ; Hoffman AR; Asmaro K; Ahmadian SS; Eltobgy MM; Nayak JV; Patel ZM; Hwang PH; Fernandez-Miranda JC
Sci Rep; 2022 Jun; 12(1):9919. PubMed ID: 35705579
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution.
Haddad AF; Young JS; Oh T; Pereira MP; Joshi RS; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Chopra AS; Sandhu NS; Theodosopoulos PV; Kunwar S; El-Sayed IH; Gurrola J; Blevins LS; Aghi MK
Neurosurg Focus; 2020 Jun; 48(6):E13. PubMed ID: 32480370
[TBL] [Abstract][Full Text] [Related]
11. GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors.
Mete O; Kefeli M; Çalışkan S; Asa SL
Mod Pathol; 2019 Apr; 32(4):484-489. PubMed ID: 30390035
[TBL] [Abstract][Full Text] [Related]
12. Giant pituitary tumors: a study based on surgical treatment of 118 cases.
Goel A; Nadkarni T; Muzumdar D; Desai K; Phalke U; Sharma P
Surg Neurol; 2004 May; 61(5):436-45; discussion 445-6. PubMed ID: 15120215
[TBL] [Abstract][Full Text] [Related]
13. Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions.
Wolfsberger S; Ba-Ssalamah A; Pinker K; Mlynárik V; Czech T; Knosp E; Trattnig S
J Neurosurg; 2004 Feb; 100(2):278-86. PubMed ID: 15086236
[TBL] [Abstract][Full Text] [Related]
14. Cavernous sinus invasion by pituitary adenomas--relationship between magnetic resonance imaging findings and histologically verified dural invasion.
Daita G; Yonemasu Y; Nakai H; Takei H; Ogawa K
Neurol Med Chir (Tokyo); 1995 Jan; 35(1):17-21. PubMed ID: 7700477
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological correlates of extrasellar growth patterns in pituitary adenomas.
Sarkar S; Chacko AG; Chacko G
J Clin Neurosci; 2015 Jul; 22(7):1173-7. PubMed ID: 25979255
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenomas: results of 684 surgically treated patients and review of the literature.
Oruçkaptan HH; Senmevsim O; Ozcan OE; Ozgen T
Surg Neurol; 2000 Mar; 53(3):211-9. PubMed ID: 10773251
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic Endonasal Pituitary Surgery For Nonfunctioning Pituitary Adenomas: Long-Term Outcomes and Management of Recurrent Tumors.
Bernat AL; Troude P; Priola SM; Elsawy A; Farrash F; Mete O; Ezzat S; Asa SL; De Almeida J; Vescan A; Monteiro E; Almeida JP; Zadeh GM; Gentili F
World Neurosurg; 2021 Feb; 146():e341-e350. PubMed ID: 33203535
[TBL] [Abstract][Full Text] [Related]
18. The Importance of Long Term Follow Up After Endoscopic Pituitary Surgery: Durability of Results and Tumor Recurrence.
Almeida JP; Tabasinejad R; Kalyvas A; Takami H; Mohan N; O'Halloran PJ; Sanchez MM; Velasquez C; Zadeh G; Gentili F
Neurol India; 2020; 68(Supplement):S92-S100. PubMed ID: 32611898
[TBL] [Abstract][Full Text] [Related]
19. Atypical pituitary adenoma: a clinicopathologic case series.
Rutkowski MJ; Alward RM; Chen R; Wagner J; Jahangiri A; Southwell DG; Kunwar S; Blevins L; Lee H; Aghi MK
J Neurosurg; 2018 Apr; 128(4):1058-1065. PubMed ID: 28598278
[TBL] [Abstract][Full Text] [Related]
20. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
Nishioka H; Fukuhara N; Horiguchi K; Yamada S
J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
